We are live on ! Find out more
OGEN icon

Oragenics

7 hedge funds and large institutions have $33M invested in Oragenics in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $26.1M → $33M (+$6.88M)

17% more funds holding

Funds holding: 67 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q3 2013 in Review

7 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2013, worth a combined $33M — up 26% from $26.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new OGEN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Third Security, adding an estimated $8.21M. The largest seller was Deutsche Bank, cutting an estimated $15K.

  • 7 institutional investors held Oragenics (OGEN) as of Q3 2013, up from 6 in Q2 2013.
  • Funds reported $33M of Oragenics stock for Q3 2013, up 26% quarter-over-quarter.
  • 1 fund opened new Oragenics positions in Q3 2013 and 0 closed out, a net change of +1 holder.
  • The largest Oragenics buyer in Q3 2013 was Third Security, an estimated $8.21M added.
  • The largest Oragenics seller in Q3 2013 was Deutsche Bank, an estimated $15K sold.

Based on aggregated 13F filings for Q3 2013.